Funding the Future of Radiology¹

Bracco Diagnostics Inc. Empowers Innovation and Advancement

Bracco Diagnostics Inc. A vanguard company

Bracco Diagnostics Inc. is unwaveringly dedicated to improving patient care—that is what drives every decision they make. They are constantly innovating, placing themselves at the forefront of numerous groundbreaking research initiatives to help advance the field of radiology. One such initiative includes their decades-long support of the Radiological Society of North America’s (RSNA) Research & Education (R&E) Foundation. Bracco's mission is to develop investigators and support innovative, lifelong research and education

$1.8 million for Radiology Research
A loyal Vanguard Company, Bracco has made a generous investment in research.

As a loyal RSNA Vanguard company, Bracco has donated over $1.8 million toward the R&E foundation’s cause in recognition of its mission. This critical investment has helped 34 grant recipients further their research and, perhaps most importantly, secure funding from additional sources, including the National Institutes of Health (NIH).

One of ten Vanguard Company
A leader in industry, Bracco is part of an elite community of corporate donors that have invested over $25 million in R&E grants since 1989.

Bracco: Proud to Be a Loyal Vanguard Company
In an era where clinical research funding faces challenges, including decreases in funding and increases in research costs, securing adequate financial support for radiology research has become increasingly crucial to the future of the industry. Add to that the competitiveness of research funding, whether looking at federal or nonfederal sources, and it becomes clear that the important cash flow required to advance the future of radiology needs to be bolstered by other sources.

34 grant recipients funded
Thanks to Bracco’s investment in R&E grants, 34 grant recipients like 2022 grantee Yoo Jin Lee, MD (pictured) have received critical grant funding.

The Impact of Grant Funding: Fostering Innovation and Collaboration
Research grants play a pivotal role in driving innovation across all diagnostic imaging modalities. Bracco understands the transformative power of grant funding in helping brilliant minds in radiology realize their potential.

Corporate donors
As a Vanguard Company, Bracco is recognized at the RSNA annual meeting and your contributions count toward technical exhibit priority points.

A Legacy of Advancing Radiology: Decades of Commitment
For over three decades, Bracco has been a driving force in supporting radiology's future through continuous investments, collaboration, and research funding with the R&E Foundation. Bracco’s commitment to funding the future of radiology exemplifies their dedication to improving patient care and driving innovation. As an RSNA Vanguard company, they continue to support early-career radiologists in the pursuit of their research goals. Through their collective efforts with the RSNA, Bracco is proud to have a role in empowering radiological investigators, accelerating scientific breakthroughs, and helping to shape the advancement of radiology.

Learn more about why Bracco champions innovation

 

Learn more

Reference:
1. Bracco Diagnostics Inc. (2023). Bracco Diagnostics Inc.: A Vanguard Company. [Infographic].

 

 

US-N/A-2300058 08/23